OpenBilldrug price receipt

NADAC week of 2026-10-14

COMBIGAN 0.2%-0.5% EYE DROPS

FDA nonproprietary name: brimonidine tartrate, timolol maleate

For 1 mL

Pharmacies pay

$39.09 – $39.16 filed

1 × $39.09128 to $39.15623 per ML (the 3 NDCs differ)

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$38.75 filed

1 × $38.74669 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.99× estimated

Medicare paid about what pharmacies pay.

Part D averages every strength and form sold under “Combigan” / “Brimonidine Tartrate/Timolol” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$49.95 – $50.03 estimated

NADAC for the pack + 15% + $5.00 fee per fill

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

COMBIGAN 0.2%-0.5% EYE DROPS is how the CMS NADAC file names this product. The FDA NDC Directory lists it as brimonidine tartrate, timolol maleate, under the trade name “COMBIGAN”.

FDA gives its dosage form as solution/ drops and its route as ophthalmic.

The labeler, the company named on the label, is Allergan, Inc.

FDA lists it under 2 Established Pharmacologic Classes: alpha-Adrenergic Agonist and beta-Adrenergic Blocker.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $39.09 – $39.16 for 1 mL, depending on the NDC ($39.09128 to $39.15623 per ML), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

NADAC also lists, on the row of its brand NDCs, what pharmacies pay for the generic equivalent, a different product: $1.97168 to $2.71747 per ML filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

All 3 NDCs

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $39.09588 per ML filed.

Of the 14 other products in FDA’s alpha-Adrenergic Agonist class priced per ML, 1 has a higher middle NADAC price and 13 a lower one. The one in the middle is BRIMONIDINE-TIMOLOL 0.2%-0.5%, at $2.15126 per ML filed (eff. 2026-09-23).

Of the 19 other products in FDA’s beta-Adrenergic Blocker class priced per ML, 2 have a higher middle NADAC price and 17 a lower one. The one in the middle is TIMOLOL 0.25% GEL-SOLUTION, at $6.37609 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $38.75 for 1 mL, at an average of $38.74669 per ML in 2024 (2024-01-01 to 2024-12-31) for “Combigan” and “Brimonidine Tartrate/Timolol”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 465,280 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for COMBIGAN 0.2%-0.5% EYE DROPS labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Combigan / Brimonidine Tartrate/Timolol: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.
Why does this page start at 1 mL?
The FDA package descriptions of this product’s NDCs give different amounts (5 mL, 10 mL, 15 mL). So the card starts at 1 ML; change it to match your prescription.